HLA-DRB1 and myeloid sarcoma: Independent studies have also shown this mutation in the MBP gene to be associated to clinical course in MS (Zhou et al., 2017) and, in association with HLA-DRB1*15:01, the allele may be considered a predisposing factor for this disorder (Nejati et al., 2017).